NEW YORK, Aug. 24, 2022
NEW YORK, Aug. 24, 2022 /PRNewswire/ — GLO Pharma, the guardian corporation of step forward subtopical skin care emblem Ourself, these days declares the appointment of Brent Saunders to its Board of Administrators. Mr. Saunders, who these days serves as Govt Chairman of The Good looks Well being Corporate, will sign up for the board efficient in an instant. His appointment provides a brand new seat to the GLO Pharma board, which now is composed of six contributors and is led via Chairman Scott L. Glenn.
Mr. Saunders is a revered innovator who brings to the Board his intensive management enjoy within the biopharma and scientific aesthetics sectors, having led a number of mergers and acquisitions and served as a couple of management roles at outstanding world pharmaceutical and healthcare corporations.
From July 2020 to Would possibly 2021, Mr. Sauders served as President, Leader Govt Officer and Chair of the Board of Administrators of Vesper Healthcare Acquisition Corp. (“Vesper”), and led Vesper’s merger with The HydraFacial Corporate to grow to be The Good looks Well being Corporate, of which he continues to function Govt Chair. Prior, he served as CEO and President of Allergan percent (“Allergan”), highest referred to as the maker of Botox, from July 2014 to Would possibly 2020, and used to be instrumental in main Allergan’s acquisition via AbbVie, Inc. He additionally served on Allergan’s board July 2014 to Would possibly 2020, and as its Chair from October 2016 to Would possibly 2020.
Mr. Saunders prior to now served as Leader Govt Officer and President of Woodland Laboratories, Inc. (“Woodland”), and later as CEO of pharmaceutical corporation Actavis, after that corporation got Woodland. Later, Saunders negotiated Actavis’ merger with Allergan, which closed at $70.5 billion. Mr. Saunders additionally held the position of Leader Govt Officer of Bausch + Lomb Integrated, a number one world eye fitness corporation, the place he oversaw the corporate’s acquisition via Valeant Prescription drugs in 2013. From 2003 to 2010, he held a lot of management positions at Schering-Plough Company, the place he led the corporate’s merger with Merck & Co. and its acquisition of Organon BioSciences. He’s the founding father of the SPAC Vesper Healthcare Acquisition, and likewise these days serves at the forums of administrators of BridgeBio Pharma, Inc. and Cisco (NASDAQ: CSCO).
“Mr. Saunders’ enjoy with scaling and remodeling biopharma and scientific aesthetics companies, first with Allergan and now with The Good looks Well being Corporate, makes him a useful asset to the GLO Pharma Board,” says Chairman Scott Glenn. “As we construct out the product providing of our shopper emblem Ourself and a roadmap of topical possible choices to scientific procedures, Brent brings implausible perception to the dialog, particularly as we broaden new innovation within the wrinkle relaxer class within the close to long term.”
This appointment follows the new announcement of Rothy’s CFO Dayna Quanbeck to the GLO Pharma Board, and release of GLO Pharma’s first shopper emblem, Ourself, in February 2022. Ourself is sponsored via $40M in investment up to now from traders together with Lightspeed Mission Companions, First Spherical Capital, and Mr. Glenn.
Manufacturing unit PR // Liz Hill
About GLO Pharma:
GLO Pharma is a biotechnology corporation devoted to growing leading edge approaches to cosmetic and aesthetics. It used to be based in 2018 via Scott Glenn and Lauren Otsuki, innovators throughout the biotechnology area for over two decades. Mr. Glenn and Ms. Otsuki prior to now based and advanced skilled skin care corporations Alastin Skin care and SkinMedica, together with a lot of pharmaceutical corporations geared toward fixing probably the most hardest scientific problems in infertility, diabetes, heart problems, and most cancers. In 2022, GLO Pharma introduced its first shopper emblem, Ourself, because the first-ever Subtopical Skin care Gadget™, bridging the space between conventional skin care merchandise and medical procedures thru the usage of biotechnology.
View authentic content material to obtain multimedia:https://www.prnewswire.com/news-releases/glo-pharma-appoints-current-executive-chairman-of-the-beauty-health-company-and-former-allergan-p.c-ceo-brent-saunders-to-its-board-of-directors-301611368.html
SOURCE GLO Pharma